160 related articles for article (PubMed ID: 31329411)
1. Mitochondria-Specific Anticancer Drug Delivery Based on Reduction-Activated Polyprodrug for Enhancing the Therapeutic Effect of Breast Cancer Chemotherapy.
Wang Y; Zhang T; Hou C; Zu M; Lu Y; Ma X; Jia D; Xue P; Kang Y; Xu Z
ACS Appl Mater Interfaces; 2019 Aug; 11(32):29330-29340. PubMed ID: 31329411
[TBL] [Abstract][Full Text] [Related]
2. Smart Unimolecular Micelle-Based Polyprodrug with Dual-Redox Stimuli Response for Tumor Microenvironment: Enhanced in Vivo Delivery Efficiency and Tumor Penetration.
Bai S; Ma X; Shi X; Shao J; Zhang T; Wang Y; Cheng Y; Xue P; Kang Y; Xu Z
ACS Appl Mater Interfaces; 2019 Oct; 11(39):36130-36140. PubMed ID: 31490659
[TBL] [Abstract][Full Text] [Related]
3. Enhanced Tumor Penetration and Chemotherapy Efficiency by Covalent Self-Assembled Nanomicelle Responsive to Tumor Microenvironment.
Ma X; Bai S; Zhang X; Ma X; Jia D; Shi X; Shao J; Xue P; Kang Y; Xu Z
Biomacromolecules; 2019 Jul; 20(7):2637-2648. PubMed ID: 31141665
[TBL] [Abstract][Full Text] [Related]
4. Reactive oxygen species-activatable camptothecin polyprodrug based dextran enhances chemotherapy efficacy by damaging mitochondria.
Zhang T; Ma X; Bai S; Wang Y; Zhang X; Lu Y; Wen F; Xue P; Kang Y; Xu Z
J Mater Chem B; 2020 Feb; 8(6):1245-1255. PubMed ID: 31957760
[TBL] [Abstract][Full Text] [Related]
5. Starburst Diblock Polyprodrugs: Reduction-Responsive Unimolecular Micelles with High Drug Loading and Robust Micellar Stability for Programmed Delivery of Anticancer Drugs.
Shi X; Hou M; Ma X; Bai S; Zhang T; Xue P; Zhang X; Liu G; Kang Y; Xu Z
Biomacromolecules; 2019 Mar; 20(3):1190-1202. PubMed ID: 30658038
[TBL] [Abstract][Full Text] [Related]
6. Mitochondria-targeted Pt(IV) prodrugs conjugated with an aggregation-induced emission luminogen against breast cancer cells by dual modulation of apoptosis and autophagy inhibition.
Su Y; Tu Y; Lin H; Wang MM; Zhang GD; Yang J; Liu HK; Su Z
J Inorg Biochem; 2022 Jan; 226():111653. PubMed ID: 34740039
[TBL] [Abstract][Full Text] [Related]
7. Dual-Responsive Polyprodrug Nanoparticles with Cascade-Enhanced Magnetic Resonance Signals for Deep-Penetration Drug Release in Tumor Therapy.
Hao Q; Wang Z; Zhao W; Wen L; Wang W; Lu S; Xing D; Zhan M; Hu X
ACS Appl Mater Interfaces; 2020 Nov; 12(44):49489-49501. PubMed ID: 33079514
[TBL] [Abstract][Full Text] [Related]
8. Mitochondria-specific drug release and reactive oxygen species burst induced by polyprodrug nanoreactors can enhance chemotherapy.
Zhang W; Hu X; Shen Q; Xing D
Nat Commun; 2019 Apr; 10(1):1704. PubMed ID: 30979885
[TBL] [Abstract][Full Text] [Related]
9. A versatile strategy to create an active tumor-targeted chemo-photothermal therapy nanoplatform: A case of an IR-780 derivative co-assembled with camptothecin prodrug.
He W; Jiang Y; Li Q; Zhang D; Li Z; Luan Y
Acta Biomater; 2019 Jan; 84():356-366. PubMed ID: 30502480
[TBL] [Abstract][Full Text] [Related]
10. Irinotecan delivery by unimolecular micelles composed of reduction-responsive star-like polymeric prodrug with high drug loading for enhanced cancer therapy.
Gao YE; Bai S; Shi X; Hou M; Ma X; Zhang T; Xiao B; Xue P; Kang Y; Xu Z
Colloids Surf B Biointerfaces; 2018 Oct; 170():488-496. PubMed ID: 29960949
[TBL] [Abstract][Full Text] [Related]
11. Selective self-induced stimulus amplification prodrug platform for inhibiting multidrug resistance and lung metastasis.
Xu C; Sun Y; Qi Y; Yu Y; He Y; Hu M; Hu Q; Wu T; Zhang D; Shang L; Deng H; Zhang Z
J Control Release; 2018 Aug; 284():224-239. PubMed ID: 29958912
[TBL] [Abstract][Full Text] [Related]
12. Synergistic antitumor efficacy of hybrid micelles with mitochondrial targeting and stimuli-responsive drug release behavior.
Chen Z; Zhang Z; Chen M; Xie S; Wang T; Li X
J Mater Chem B; 2019 Mar; 7(9):1415-1426. PubMed ID: 32255012
[TBL] [Abstract][Full Text] [Related]
13. Gemcitabine-camptothecin conjugates: a hybrid prodrug for controlled drug release and synergistic therapeutics.
Hou M; Xue P; Gao YE; Ma X; Bai S; Kang Y; Xu Z
Biomater Sci; 2017 Aug; 5(9):1889-1897. PubMed ID: 28681888
[TBL] [Abstract][Full Text] [Related]
14. Reduction stimuli-responsive unimolecular polymeric prodrug based on amphiphilic dextran-framework for antitumor drug delivery.
Bai S; Gao YE; Ma X; Shi X; Hou M; Xue P; Kang Y; Xu Z
Carbohydr Polym; 2018 Feb; 182():235-244. PubMed ID: 29279120
[TBL] [Abstract][Full Text] [Related]
15. Reduction-responsive amphiphilic polymeric prodrugs of camptothecin-polyphosphoester for cancer chemotherapy.
Jin H; Sun M; Shi L; Zhu X; Huang W; Yan D
Biomater Sci; 2018 May; 6(6):1403-1413. PubMed ID: 29595843
[TBL] [Abstract][Full Text] [Related]
16. Dual Stable Nanomedicines Prepared by Cisplatin-Crosslinked Camptothecin Prodrug Micelles for Effective Drug Delivery.
Li Y; Lu H; Liang S; Xu S
ACS Appl Mater Interfaces; 2019 Jun; 11(23):20649-20659. PubMed ID: 31117440
[TBL] [Abstract][Full Text] [Related]
17. Angiopep2-Conjugated Star-Shaped Polyprodrug Amphiphiles for Simultaneous Glioma-Targeting Therapy and MR Imaging.
Wang X; Liu G; Chen N; Wu J; Zhang J; Qian Y; Zhang L; Zhou D; Yu Y
ACS Appl Mater Interfaces; 2020 Mar; 12(10):12143-12154. PubMed ID: 32078286
[TBL] [Abstract][Full Text] [Related]
18. Polyprodrug nanomedicine for chemiexcitation-triggered self-augmented cancer chemotherapy and gas therapy.
Wang Q; Zhang C; Zhao Y; Jin Y; Zhou S; Qin J; Zhang W; Hu Y; Chen X; Yang K
Biomaterials; 2024 Sep; 309():122606. PubMed ID: 38776593
[TBL] [Abstract][Full Text] [Related]
19. Reduction-active polymeric prodrug micelles based on α-cyclodextrin polyrotaxanes for triggered drug release and enhanced cancer therapy.
Bai S; Hou M; Shi X; Chen J; Ma X; Gao YE; Wang Y; Xue P; Kang Y; Xu Z
Carbohydr Polym; 2018 Aug; 193():153-162. PubMed ID: 29773367
[TBL] [Abstract][Full Text] [Related]
20. "Bottom-up" Construction of Multi-Polyprodrug-Arm Hyperbranched Amphiphiles for Cancer Therapy.
Sun P; Chen D; Deng H; Wang N; Huang P; Jin X; Zhu X
Bioconjug Chem; 2017 May; 28(5):1470-1480. PubMed ID: 28441015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
